|Mr. James C. Clemmer||CEO, Pres & Director||1.44M||N/A||1964|
|Mr. Michael C. Greiner||Exec. VP & CFO||729.99k||N/A||1973|
|Mr. David D. Helsel||Sr. VP of Global Operations and R&D||518.23k||N/A||1964|
|Mr. Stephen A. Trowbridge||Sr. VP, Gen. Counsel & Assistant Sec.||519.09k||N/A||1974|
|Mr. Benjamin H. Davis||Sr. VP of Bus. Devel.||N/A||N/A||1964|
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems; IsoLoc Endorectal Balloon's; alatus vaginal balloon packing systems; and OARtrac system, which offers real-time dose data physically delivered during various cancer treatments. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
AngioDynamics, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 3. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 5; Compensation: 1.